Epoetin alfa RB

DRUG2 trials

Sponsors

Amgen

Conditions

Chronic Kidney DiseaseNephrology

Phase 3

Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis

CompletedNCT00146224

AmgenNephrology

Start: 2005-09-30End: 2007-01-31Target: 420Updated: 2010-02-26

Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

TerminatedNCT00156962

AmgenChronic Kidney Disease

Start: 2005-04-30End: 2007-03-31Target: 850Updated: 2008-07-21